Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral Modified Cobratoxin in Adrenomyeloneuropathy
2004-002200-14Phase 3Completed
- Sponsor
- ReceptoPharm
- Start
- Jul 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in adrenomyeloneuropathy (AMN) comparing Modified cobratoxin with Placebo (2 arms). Primary endpoints: Timed Walk (10 meters) and Ambulatory score. Started Jul 2005; status: completed.
02
Drugs
cobratoxin
03
Conditions
adrenomyeloneuropathy (AMN)
Beyond the preview
Go deeper on 2004-002200-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002200-14.